A Principal Investigator from McMaster University in Ontario leads a large international clinical trial testing drugs targeting COVID-19 including ivermectin, metformin and fluvoxamine. With a growing number of studies indicating the potential efficacy of ivermectin, as well as some evidence that fluvoxamine shows promise, this large study could potentially take the evidence to the next level of credibility. The results of this study could be available within just a few months. The study is funded by the Bill and Melinda Gates Foundation as well as FastGrants.
Led by Edward Mills, the Together COVID-19 Trial involves the McMaster research team as well as partners including Cardresearch and the Pontifical Catholic University of Minas Gerais in Brazil and the University of Stellenbosch of South Africa.
Ivermectin Gains Momentum
The growing evidence becomes difficult to ignore--and with Bill and Melinda Gates putting money into study the inexpensive drug costing less than $5 per treatment and which is on the list of World Health Organization essential medicines shows growing interest. TrialSite has chronicled ivermectin studies all over the world and organizations, such as t...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).